Table 2 Treatment characteristics
Treatment characteristics | Group 1 | Group 2 | P |
|---|---|---|---|
SBRT dose (Gy) | |||
-Range | 25-35 | 15-35 | |
-Median | 30 | 30 | |
Target volume (mL) | |||
-Range | 4-214 | 5-166 | 0.551 |
-Median | 54 | 46 | |
Number of fractions | |||
-Range | 3-5 | 4-6 | |
-Median | 5 | 5 | |
Carotid artery dose (Gy) | |||
-Range | 2.5-42.5 | 6.8-39.1 | >0.05 |
-Median | 35 | 34.9 | |
Temporomandibular joint dose (Gy) | |||
- Range | 0-42 | 0-33.5 | 0.217 |
-Median | 24 | 14.7 | |
Temporal lobe dose (Gy) | |||
-Range | 0-44.1 | 0-35.9 | |
-Median | 21.7 | 21.5 | |
Conformity index | |||
-Range | 1.1-2.46 | 1.14-2.23 | |
-Median | 1.57 | 1.54 | |
Homogeneity index | |||
-Range | 1.14-1.67 | 1.15-1.43 | |
-Median | 1.32 | 1.28 | |
Prescribed isodose (Gy) | |||
-Range | 60-88 | 70-87 | |
-Median | 77 | 78 | |
Collimator size (mm) | |||
- Range | 10-40 | 12.5-35 | |
-Median | 20 | 20 | |
Beam number | |||
-Range | 142-369 | 121-481 | |
-Median | 206 | 200 |